Hong Kong-listed innovative pharmaceutical concept stocks continued to rebound, with WuXi Biologics rising more than 6%.

Hong Kong stocks of innovative pharmaceutical concept stocks continue to rebound, Geli Pharmaceutical-B rose more than 9%, Pharmaron Biological rose more than 6%, Rongchang Biological, NovaMed Therapeutics, and Sinobioway Biomedicine followed the rise.